Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Highlight
  • Published:

Radiotherapy

NSCLC treatment—reducing costs and improving outcomes

Nature Reviews Clinical Oncology volume 7, page 610 (2010)Cite this article

Subjects

Access through your institution
Buy or subscribe

For patients with medically inoperable NSCLC (who are typically elderly with comorbidities), SBRT offers an attractive alternative to conventional EBRT. “One of the benefits of SBRT versus standard EBRT is the number of visits a patient needs to make for their treatment,” comments lead reseacher Thomas Lanni Jr, from the William Beaumont Hospital, MI, USA. Indeed, SBRT is associated with a shorter overall treatment time and a smaller number of fractions compared with EBRT, which can potentially improve the patient's quality of life.

To assist the decision-making process as to whether SBRT should be introduced as the new standard therapy for medically inoperable NSCLC, Lanni's team compared treatment costs and outcomes in 86 patients with stage I NSCLC who received either SBRT or EBRT. Treatment costs were calculated according to the average number of fractions received by each patient. Hospital billing costs and patient reimbersment costs were also calculated.

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

ORIGINAL RESEARCH PAPER

  1. Lanni, T. B. Jr et al. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer. Am. J. Clin. Oncol. doi:10.1097/COC.obo13e3181ec63ae

Download references

Authors
  1. Lisa Richards
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Richards, L. NSCLC treatment—reducing costs and improving outcomes. Nat Rev Clin Oncol 7, 610 (2010). https://doi.org/10.1038/nrclinonc.2010.160

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nrclinonc.2010.160

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing